Pfizer & others should be ashamed that they have raised drug prices for no reason. They are merely taking advantage of the poor & others unable to defend themselves, while at the same time giving bargain basement prices to other countries in Europe & elsewhere. We will respond!

President Trump's tweet comes only days after reports that Pfizer raised prices on dozens of drugs starting in July, with many increases coming in at 9%. Before the reports, Trump said in late May that drugmakers were planning "massive" voluntary price cuts.

At the same time, many industry players have committed to limiting their hikes amid a yearslong examination of pharmaceutical pricing. Allergan and AbbVie are among companies that have pledged to keep price hikes to once per year and under 10%.

After a round of increases last year, members of the Interfaith Center on Corporate Responsibility wrote to Pfizer CEO Ian Read to say they're worried the company "has responded to the intense scrutiny on pricing over the past year by continuing a relentless march forward on drug price increases." In the letter, ICCR investor members said they believe Pfizer is “increasingly out of step with leaders in the sector.”



A company spokesperson declined to respond to the letter but reiterated a statement that the company "has always priced responsibly" and that it believes "innovative medicines are one of the most valuable and cost-effective segments of healthcare spend and are an important part of the solution to growing healthcare costs."

中新社北京10月30日电 (王珏)中国外交部发言人华春莹30日在例行记者会上表示,中方一贯反对美国在韩国部署“萨德”系统。希望韩方妥善处理相关问题。

今年4月,新泽西州民主党参议员科里·布克(Cory Booker)发表讲话。他认为,企业本可以利用储蓄来降低价格。相反,这位参议员在一份报告中指出,辉瑞、默克、艾伯维、安进和新机生物(Celgene)在税法通过之前或之后,开始了价值450亿美元的股票回购。企业还宣布了新的制造业和研发投资,并通过税收改革提高了非高管薪酬、慈善捐赠等方面的投入。

RELATED: Trump says drug makers plan to offer 'massive drops' in prices—fact or fantasy?